Gefitinib for Chinese patients with advanced non-small-cell lung cancer

被引：0
|
作者：
Xiaotong, Z [1 ]
Longyun, L [1 ]
Xinlin, MU [1 ]
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Dis, Beijing 100037, Peoples R China
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [41] A review of the benefit risk profile of gefitinib in Asian patients with advanced non-small-cell lung cancer
    Park, K
    Goto, K
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) : 561 - 573
  • [42] Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancer
    Gelibter, A
    Ceribelli, A
    Pollera, CF
    Milella, M
    Moscetti, L
    Sperduti, I
    Cognetti, F
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (12) : 783 - 788
  • [43] Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
    F Cappuzzo
    S Bartolini
    G L Ceresoli
    S Tamberi
    A Spreafico
    L Lombardo
    V Gregorc
    L Toschi
    C Calandri
    E Villa
    L Crinò
    [J]. British Journal of Cancer, 2004, 90 : 82 - 86
  • [44] Impact of gefitinib (‘Iressa’) treatment on the quality of life of patients with advanced non-small-cell lung cancer
    Alain Gelibter
    Anna Ceribelli
    Camillo F. Pollera
    Michele Milella
    Luca Moscetti
    Isabella Sperduti
    Francesco Cognetti
    [J]. Journal of Cancer Research and Clinical Oncology, 2005, 131 : 783 - 788
  • [45] Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
    Liang, Jun-Li
    Ren, Xiao-Cang
    Lin, Qiang
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 761 - 769
  • [46] Gefitinib in a molecularly defined chemonaive population with advanced non-small-cell lung cancer
    Teck, Lim Wan
    Huat, Tan Bee
    Ravindran, Kanesvaran
    Balram, Chowbay
    [J]. PHARMACOGENOMICS, 2008, 9 (10) : 1381 - 1382
  • [47] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Rossi, Antonio
    La Salvia, Anna
    Di Maio, Massimo
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (03) : 171 - 180
  • [48] EFFECTIVENESS OF ERLOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER AFTER FAILURE OF GEFITINIB
    Saito, Haruhiro
    Murakami, Shuji
    Honda, Takeshi
    Kondo, Tetsuro
    Oshita, Fumihiro
    Noda, Kazumasa
    Yamada, Kouzo
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [49] Gefitinib - A review of its use in the management of advanced non-small-cell lung cancer
    Frampton, JE
    Easthope, SE
    [J]. DRUGS, 2004, 64 (21) : 2475 - 2492
  • [50] Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib
    Song, Zhengbo
    Zhang, Yiping
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 875 - 878
12345